Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...
LSF Miami Bridge Youth & Family Services has announced the appointment of Dr. Toshiba L. Mitchell as program director. A distinguished educator, leader and advocate for youth and families, Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback